|
|
|
|
|
by v8xi
962 days ago
|
|
It's important that the CARVac (mRNA vaccine) part of the treatment targets specifically (though how specific, I dont know) dendritic cells which are "professional" antigen-presenting cells in the immune system. During an immune response, dendritic cells gobble up antigens and present them on their surface to help train the immune system so it's more trying to hijack that (very important) part of the immune response rather than training the immune system (and resulting in the death of the "infected" cells) in the way we're used to understanding mRNA vaccines. |
|